Kenneth Irwin Shine Sells 163 Shares of UnitedHealth Group Inc (UNH) Stock

UnitedHealth Group Inc (NYSE:UNH) Director Kenneth Irwin Shine sold 163 shares of the company’s stock in a transaction dated Friday, November 9th. The stock was sold at an average price of $274.83, for a total transaction of $44,797.29. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Shares of NYSE UNH opened at $264.10 on Thursday. UnitedHealth Group Inc has a twelve month low of $208.48 and a twelve month high of $278.00. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.69. The stock has a market capitalization of $262.04 billion, a price-to-earnings ratio of 26.23, a price-to-earnings-growth ratio of 1.57 and a beta of 0.78.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.63%. The company had revenue of $56.56 billion during the quarter, compared to the consensus estimate of $56.34 billion. During the same period in the prior year, the company earned $2.66 EPS. UnitedHealth Group’s revenue was up 12.4% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Inc will post 12.81 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s payout ratio is 35.75%.

Hedge funds and other institutional investors have recently modified their holdings of the business. WoodTrust Financial Corp lifted its stake in UnitedHealth Group by 2.5% during the third quarter. WoodTrust Financial Corp now owns 7,823 shares of the healthcare conglomerate’s stock valued at $2,081,000 after buying an additional 189 shares in the last quarter. Advisors Capital Management LLC lifted its stake in UnitedHealth Group by 15.2% during the third quarter. Advisors Capital Management LLC now owns 1,437 shares of the healthcare conglomerate’s stock valued at $382,000 after buying an additional 190 shares in the last quarter. Chicago Partners Investment Group LLC lifted its stake in UnitedHealth Group by 26.5% during the second quarter. Chicago Partners Investment Group LLC now owns 920 shares of the healthcare conglomerate’s stock valued at $226,000 after buying an additional 193 shares in the last quarter. Highland Capital Management LLC lifted its stake in UnitedHealth Group by 0.5% during the third quarter. Highland Capital Management LLC now owns 36,128 shares of the healthcare conglomerate’s stock valued at $9,612,000 after buying an additional 194 shares in the last quarter. Finally, OLD Mutual Customised Solutions Proprietary Ltd. lifted its stake in UnitedHealth Group by 1.2% during the second quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 17,096 shares of the healthcare conglomerate’s stock valued at $4,194,000 after buying an additional 200 shares in the last quarter. 85.47% of the stock is owned by institutional investors.

Several research firms have recently commented on UNH. BMO Capital Markets upped their price target on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, October 18th. Argus upped their price target on shares of UnitedHealth Group to $285.00 and gave the stock a “buy” rating in a research report on Thursday, October 18th. Oppenheimer upped their price target on shares of UnitedHealth Group from $276.00 to $295.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 17th. Royal Bank of Canada upped their price target on shares of UnitedHealth Group to $308.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 17th. Finally, Piper Jaffray Companies upped their price target on shares of UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 17th. One equities research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $289.41.

TRADEMARK VIOLATION WARNING: This news story was posted by WKRB News and is the sole property of of WKRB News. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.wkrb13.com/2018/11/15/kenneth-irwin-shine-sells-163-shares-of-unitedhealth-group-inc-unh-stock.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Return on Investment (ROI)

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply